Investigating the polygenic control of susceptibility to drug-induced liver disease (DILD) using varied strains of mice.

被引：0
|
作者：
Welch, K
Reilly, T
Brady, J
Pise-Masison, C
Radonovich, M
Pohl, L
机构：
[1] NHLBI, US Dept HHS, NIH, Bethesda, MD 20892 USA
[2] NCI, US Dept HHS, NIH, Bethesda, MD 20892 USA
来源：
TOXICOLOGICAL SCIENCES | 2003年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
954
引用
收藏
页码：197 / 197
页数：1
相关论文
共 18 条
  • [1] Proteomic identification of susceptibility factors in drug-induced liver disease (DILD)
    Welch, KD
    Reilly, TP
    Wen, B
    Goodlett, DR
    Yi, EC
    Lee, H
    Nelson, SD
    Pohl, LR
    [J]. DRUG METABOLISM REVIEWS, 2004, 36 : 228 - 228
  • [2] Resveratrol promotes liver regeneration in drug-induced liver disease in mice
    de Moraes, Alan Cesar Nunes
    de Andrade, Cherley Borba Vieira
    Ramos, Isalira Peroba Rezende
    Dias, Marlon Lemos
    Batista, Cintia Marina Paz
    Pimentel, Cibele Ferreira
    de Carvalho, Jorge Jose
    Goldenberg, Regina Coeli dos Santos
    [J]. FOOD RESEARCH INTERNATIONAL, 2021, 142
  • [3] Susceptibility to drug-induced liver disease: Clues from mouse models
    Kaplowitz, Neil
    [J]. DRUG METABOLISM REVIEWS, 2006, 38 : 37 - 37
  • [4] Proteomic identification of potential susceptibility factors in drug-induced liver disease
    Welch, KD
    Wen, B
    Goodlett, DR
    Yi, EC
    Lee, H
    Reilly, TP
    Nelson, SD
    Pohl, LR
    [J]. CHEMICAL RESEARCH IN TOXICOLOGY, 2005, 18 (06) : 924 - 933
  • [5] Susceptibility to Hepatotoxic Drug-Induced Liver Injury Increased After Traumatic Brain Injury in Mice
    Yuan, Hengjie
    Tian, Ye
    Jiang, Rongcai
    Wang, Yuanzhi
    Nie, Meng
    Li, Xiaochun
    He, Yifan
    Liu, Xuanhui
    Zhao, Ruiting
    Zhang, Jingyue
    [J]. JOURNAL OF NEUROTRAUMA, 2024, 41 (11-12) : 1425 - 1437
  • [6] Role of anti-inflammatory and other factors in determining susceptibility to idiosyncratic drug-induced liver disease
    Pohl, LR
    [J]. DRUG METABOLISM REVIEWS, 2003, 35 : 3 - 3
  • [7] Role of reactive metabolites and other risk factors in determining susceptibility to drug-induced liver disease.
    Pohl, Lance R.
    [J]. CHEMICAL RESEARCH IN TOXICOLOGY, 2006, 19 (12) : 1680 - 1681
  • [8] Prediction of Drug-induced Liver Injury in Humans by Using Chimeric PXB-mice® with Highly Humanized Liver
    Nagatsuka, Shin-Ichiro
    Hynes, Darina
    Ninomiya, Shin-Ichi
    Kakuni, Masakazu
    Tateno, Chise
    Shimada, Takashi
    Yamazoe, Yasushi
    [J]. DRUG METABOLISM REVIEWS, 2010, 42 : 161 - 161
  • [9] Inhibition of Drug-Induced Liver Injury in Mice Using a Positively Charged Peptide That Binds DNA
    Marques, Pedro E.
    Vandendriessche, Sofie
    de Oliveira, Thiago H. C.
    Crijns, Helena
    Lopes, Mateus E.
    Blanter, Marfa
    Schuermans, Sara
    Yu, Karen
    Poosti, Fariba
    Vanheule, Vincent
    Janssens, Rik
    Boff, Daiane
    Kungl, Andreas J.
    Menezes, Gustavo B.
    Teixeira, Mauro M.
    Proost, Paul
    [J]. HEPATOLOGY COMMUNICATIONS, 2021, 5 (10) : 1737 - 1754
  • [10] Investigating the Mechanism of Action of Frankincense against Drug-Induced Liver Injury Using Network Pharmacology and Molecular Docking
    Liao, Yu-cheng
    Wang, Jing-wen
    Yang, Qian
    Wang, Wen-jun
    Zhao, Chao
    Sun, Lian
    Wen, Ai-dong
    Li, Rui-li
    Ding, Yi
    [J]. LETTERS IN DRUG DESIGN & DISCOVERY, 2021, 18 (10) : 976 - 986
12